Cargando…
Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018877/ https://www.ncbi.nlm.nih.gov/pubmed/35440079 http://dx.doi.org/10.1038/s41419-022-04743-7 |
_version_ | 1784689127177846784 |
---|---|
author | Ritter, Violetta Krautter, Franziska Klein, Diana Jendrossek, Verena Rudner, Justine |
author_facet | Ritter, Violetta Krautter, Franziska Klein, Diana Jendrossek, Verena Rudner, Justine |
author_sort | Ritter, Violetta |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9018877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-90188772022-04-28 Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy Ritter, Violetta Krautter, Franziska Klein, Diana Jendrossek, Verena Rudner, Justine Cell Death Dis Correction Nature Publishing Group UK 2022-04-19 /pmc/articles/PMC9018877/ /pubmed/35440079 http://dx.doi.org/10.1038/s41419-022-04743-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Ritter, Violetta Krautter, Franziska Klein, Diana Jendrossek, Verena Rudner, Justine Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy |
title | Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy |
title_full | Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy |
title_fullStr | Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy |
title_full_unstemmed | Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy |
title_short | Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy |
title_sort | correction to: bcl-2/bcl-xl inhibitor abt-263 overcomes hypoxia-driven radioresistence and improves radiotherapy |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018877/ https://www.ncbi.nlm.nih.gov/pubmed/35440079 http://dx.doi.org/10.1038/s41419-022-04743-7 |
work_keys_str_mv | AT rittervioletta correctiontobcl2bclxlinhibitorabt263overcomeshypoxiadrivenradioresistenceandimprovesradiotherapy AT krautterfranziska correctiontobcl2bclxlinhibitorabt263overcomeshypoxiadrivenradioresistenceandimprovesradiotherapy AT kleindiana correctiontobcl2bclxlinhibitorabt263overcomeshypoxiadrivenradioresistenceandimprovesradiotherapy AT jendrossekverena correctiontobcl2bclxlinhibitorabt263overcomeshypoxiadrivenradioresistenceandimprovesradiotherapy AT rudnerjustine correctiontobcl2bclxlinhibitorabt263overcomeshypoxiadrivenradioresistenceandimprovesradiotherapy |